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Abstract
Introduction: It has been supposed that endocrine disturbances might be responsible for polycystic ovary syndrome (PCOS)-associated oxida-
tive stress, with special emphasis on hyperandrogenism. Considering the potential relationship between hyperandrogenism and increased 
free radical production, parameters of oxidative stress were determined in non-obese normoinsulinemic adolescent girls newly diagnosed 
with PCOS.
Materials and methods: Nitrotyrosine, thiol group concentrations, glutathione peroxidase, and superoxide dismutase activities were de-
termined under fasting conditions and during oral glucose tolerance test (OGTT) in 35 PCOS patients and 17 controls. Insulin resistance 
was assessed by the homeostasis model (HOMA-IR), HOMA β, insulinogenic index (IGI), Matsuda insulin sensitivity index (ISI), and AUC 
for glucose. Glutathione S-transferases (GSTs) polymorphisms were determined by PCR.
Results: Under fasting conditions, no significant difference of oxidative stress parameters was found between PCOS and controls. Acute 
hyperglycaemia during OGTT induced significant alteration in parameters of oxidative protein damage in PCOS patients. Alteration in 
nitrotyrosine concentrations correlated with testosterone, DHEAS, androstenediones, FAI, and LH, while changes in thiol groups cor-
related with DHEAS. Significant inverse association was found between LH and ISI, as well as AUC glucose and thiol groups. PCOS girls, 
carriers of GSTM1-null genotype, had significantly lower testosterone in comparison to ones with GSTM1-active genotype.
Conclusions: PCOS girls exhibited high free radical production together with unchanged antioxidant enzymatic capacity, independently 
from obesity and insulin resistance. Based on associations between oxidative stress parameters and testosterone, DHEAS, and androsten-
edione, it can be suggested that increased free radical production, probably as a consequence of hyperandrogenaemia, is an early event 
in the development of PCOS. (Endokrynol Pol 2018; 69 (4): 366–374)
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Streszczenie
Wstęp: Istnieją przypuszczenia, że zaburzenia hormonalne mogą odpowiadać za stres oksydacyjny, związany z zespołem policystycznych 
jajników (polycystic ovary syndrome; PCOS), ze szczególnym naciskiem na hiperandrogenizm. Biorąc pod uwagę potencjalny związek między 
hiperandrogenizmem a zwiększoną produkcją wolnych rodników, parametry stresu oksydacyjnego określono u nieotyłych, dorastających 
dziewcząt z normoinsulinemią, u których niedawno zdiagnozowano zespół policystycznych jajników (PCOS). 
Materiał i metody: W warunkach na czczo oraz podczas doustnego testu obciążenia glukozą (oral glucose tolerance test; OGTT) określono 
stężenie nitrotyrozyny, stężenia grup tiolowych, aktywność peroksydazy glutationowej i dysmutazy ponadtlenkowej u 35 pacjentów 
z PCOS oraz 17 osób z grupy kontrolnej. Insulinooporność oceniano za pomocą modelu homeostazy (HOMA-IR), HOMA β, współczynnika 
insulinogennego IGI (insulinogenic index; IGI), wskaźnika insulinowrażliwości (Matsuda insulin sensitivity index; ISI) i pola pod krzywą (area 
under the curve; AUC) stężenia glukozy we krwi. Polimorfizmy S-transferaz glutationowych (GSTs) określono za pomocą metody PCR. 
Wyniki: W warunkach na czczo nie stwierdzono istotnej różnicy parametrów stresu oksydacyjnego między pacjentami z PCOS a osobami 
z grupy kontrolnej. Ostra hiperglikemia podczas trwania OGTT wywołała istotne zmiany parametrów oksydacyjnych uszkodzeń białek 
u pacjentów z PCOS. Zmiana stężeń nitrotyrozyny korelowała ze stężeniem testosteronu, siarczanu dehydroepiandrosteronu (dehydroe-
piandrosterone sulphate; DHEAS), androstenedionów, współczynnikiem wolnych androgenów (free androgen index; FAI) oraz hormonem 
luteinizującym (luteinising hormone; LH), podczas, gdy zmiany stężeń grup tiolowych korelowały z DHEAS. Stwierdzono istotną odwrotną 
zależność między LH a ISI, jak również między AUC stężenia glukozy a grupami tiolowymi. Dziewczęta z PCOS, nosicielki genotypu 
GSTM1-null, wykazywały niższe stężenie testosteronu w porównaniu z dziewczętami z genotypem GSTM1-active.
Djuro Macut, M.D., Ph.D., Clinic of Endocrinology, Diabetes, and Metabolic Diseases, dr Subotica 13, 11000 Belgrade, Serbia; phone:  
+381 11 3639742, fax: +381 11 2685357, e-mail: djmacut@gmail.com
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Wnioski: U dziewcząt z PCOS wykazano wyższą produkcję wolnych rodników wraz z niezmienioną enzymatyczną zdolnością 
antyoksydacyjną, niezależnie od otyłości i oporności na insulinę. Biorąc pod uwagę związek między parametrami stresu oksydacyjnego 
i testosteronu, DHEAS i androstenedionów, można uznać, że zwiększona produkcja wolnych rodników, prawdopodobnie jako konsek-
wencja hiperandrogenemii, występuje na wczesnym etapie rozwoju PCOS. (Endokrynol Pol 2018; 69 (4): 367–374) 
Słowa kluczowe: stres oksydacyjny, nitrotyrozyna, testosteron, hiperandrogenizm, zespół policystycznych jajników
link between hormonal status and oxidative stress of 
adolescent, normoinsulinemic PCOS girls has not been 
investigated yet. Moreover, genetic polymorphisms of 
glutathione transferases (GSTs), enzymes involved in 
detoxification of different electrophilic compounds, 
including steroid hormones and free radicals, has not 
been addressed in this syndrome. 
In this line, we investigated whether the hormo-
nal status of non-obese adolescent girls with PCOS 
could affect level of oxidative stress before and after 
glucose challenge. During oral glucose tolerance test 
(OGTT) oxidative stress by-products, nitrotyrosine, 
and thiol groups, together with activity of key anti-
oxidant enzymes, glutathione peroxidase (GPX), and 
superoxide dismutase (SOD), were measured. Genetic 
polymorphisms of main cytosolic GST classes in PCOS 
patients and age-matched healthy controls were also 
determined.
Materials and methods
Subjects
Thirty-five newly diagnosed adolescent girls with 
PCOS (age = 16.37 ± 0.94 years; mean ± SD) and 17 
age- and BMI-matched healthy controls (16.71 ± 1.11 
years old) (Table I) with regular ovulatory menstrual 
Table I. Basal clinical parameters in non-obese PCOS patients 
and age-matched controls
Tabela I. Podstawowe parametry kliniczne nieotyłych 
pacjentów z PCOS i dobranych pod względem wieku osób 
z grupy kontrolnej 
PCOS 
(n = 35)
Controls 
(n = 17)
p 
Age (years) 16.37 ± 0.94 16.71 ± 1.11 0.251
BMI [kg/m2] 22.52 ± 2.45 22.53 ± 2.69 0.982
Waist circumference, 
WC [cm]
75.88 ± 6.42 75.23 ± 5.59 0.723 
Hip circumference, 
HC [cm]
95.36 ± 5.61 94.80 ± 6.90 0.754
Waist-to-hip ratio, 
WHR [cm]
0.80 ± 0.05 0.79 ± 0.04 0.932
Values are presented as mean ± standard deviation. Statistical differences 
in the variables between groups were assessed by the t-test for independent 
samples. A p-value < 0.05 was considered statistically significant. PCOS, 
polycystic ovary syndrome; n, number of samples; BMI, body mass index;  
WC, waist circumference; HC, hip circumference; WHR, waist-to-hip ratio
Introduction
Polycystic ovary syndrome (PCOS), when manifested 
with puberty, is characterised by all three of the follow-
ing criteria: clinical or biochemical hyperandrogenism, 
oligo/anovulation, and polycystic ovaries [1, 2]. In ad-
dition to its relatively high prevalence, this syndrome 
has an important negative impact on health because it 
is frequently associated with infertility, obesity, insulin 
resistance, and metabolic syndrome, as well as higher 
risk for cardiovascular disease [3]. It has been sug-
gested that increased gonadotropin-releasing hormone 
(GnRH) pulse frequency causes excessive secretion of 
luteinising hormone (LH) during the early phase of the 
development of the syndrome [4]. This further induces 
premature acquisition of LH receptors on growing 
ovarian follicles, leading to increased ovarian androgen 
production [5]. In addition to ovarian hyperthecosis and 
the resulting increase in androgen production, it has 
been underlined that different genetic, lifestyle, and 
environmental factors might significantly contribute 
to its pathophysiology [6].
It has been suggested that the parameters of oxida-
tive stress might have complex associations with the 
etiopathogenesis, clinical manifestations, and possibly 
the development of unfavourable cardiometabolic 
outcomes in PCOS women [7]. In particular, hyperan-
drogenism seems to represent the main progenitor of 
increased production of reactive oxygen species (ROS). 
Oxidative stress, in turn, could stimulate the expres-
sion of ovarian steroidogenic enzymes involved in 
androgen production and proliferation of theca cells [7]. 
Furthermore, oxidative stress impairs insulin signalling, 
resulting in a compensatory hyperinsulinaemia, which 
can further stimulate thecal steroidogenesis. Overall, it 
can be concluded that oxidative stress, together with 
low-grade inflammation, insulin resistance, and/or 
hyperinsulinaemia, significantly contributes to hyper-
androgenism and anovulation, as well as cardiovascular 
disorders accompanied by PCOS [8, 9].
Our previous results indicate that non-obese PCOS 
women are prone to oxidative stress induced primarily 
by glucose challenge, but this seems not to be related 
to the direct effect of hyperinsulinaemia during clamp 
[10, 11]. We also found that oxidative stress markers 
were related to indices of insulin resistance as well as 
circulating testosterone [10, 11]. However, the potential 
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cycles referred to the Department of Pediatric and 
Adolescent Gynecology, Mother and Child Health Care 
Institute of Serbia, Belgrade and were enrolled in this 
study. Diagnosis of PCOS was made on the basis of 
the revised 2003 Rotterdam ESHRE/ARSM consensus 
criteria (2004) [1] adapted for adolescence according to 
Carmina et al. [2]. Thus, all patients fulfilled all three of 
the Rotterdam criteria: oligo- or amenorrhoea and/or 
anovulation, clinical and/or biochemical signs of hy-
perandrogenism, and polycystic ovarian morphology 
on ultrasonographic examination. Oligomenorrhoea 
and amenorrhoea were defined according to Laven 
et al. [12]. Anovulation was diagnosed when proges-
terone concentrations measured on the 21th day of 
spontaneous or progestin-induced menstrual cycle 
were measured at less than 10 nmol/L. Hirsutism, 
a clinical sign of hyperandrogenism, was declared 
when the Ferriman-Gallwey (F-G) score was calculated 
as ≥ 8 [13]. Hyperandrogenemia, a biochemical sign 
of hyperandrogenism, was diagnosed when serum 
total testosterone concentrations were greater than 
2 nmol/L. Ovaries were diagnosed as polycystic by 
transabdominal ultrasonography when the ovarian 
volume was greater than 10 mL and/or when 12 or 
more follicles measuring 2 to 9 mm in diameter were 
present [14]. Thus, the healthy controls had proges-
terone concentrations greater than 10 nmol/L on the 
21th day of a regular menstrual cycle, no clinical or 
hormonal signs of hyperandrogenism, and no poly-
cystic ovarian morphology on ultrasound examination. 
Exclusion criteria for all the participants were as 
follows: time of menarche less than three years before 
inclusion in the study, pregnancy, Cushing’s syndrome, 
impaired fasting glucose, hyperprolactinemia, thyroid 
dysfunction or other endocrine disorder as well as acute 
or chronic ailment or any rheumatologic diseases, and 
BMI > 30 kg/m2. None of the participants had received 
any kind of antibiotics or any kind of hormonal treat-
ment for at least six months prior to the beginning of the 
study. Patients and controls had no history of cigarette 
smoking or alcohol consumption.
Protocol
All subjects were seen in the early follicular phase of 
a spontaneous or progesterone-induced menstrual 
cycle (day 3–5) if not otherwise stated. At the initial 
visit a clinical examination was performed by the same 
researcher (I.M.). Body mass index (BMI, kg/m2) was 
used as a marker of overall obesity. Abdominal obesity 
was calculated as waist-to-hip ratio (WHR). Waist cir-
cumference (WC, cm) was measured at the narrowest 
part of the torso as seen from the front, whereas hip 
circumference (HC, cm) was the maximum extension 
of the buttocks as seen from the side. Blood sampling 
was performed from the antecubital vein after 12-hour 
fasting between 8 a.m. and 9 a.m. Standard oral glucose 
tolerance test (OGTT) was performed after overnight 
fast, with 75 g of glucose. Glucose were determined at 
0, 30, 60, 90, and 120 min of the test.
The study was approved by the Ethics Committee 
of the Mother and Child Health Care Institute of Serbia, 
and written, informed consent was obtained from all 
study participants or from their parents.
Biochemical and hormonal testing 
If not stated differently, all biochemical and hormonal 
testing were determined using an automatic analyser 
Roche Hitachi 6000 Cobas c501 (Roche, Mannheim, 
Germany). Plasma glucose (mmol/L) was determined 
by enzymatic method. Plasma FSH (U/L), LH (U/L), 
total testosterone (nmol/L), progesterone (nmol/L), 
and insulin (mIU/L) were measured by electroche-
miluminescence immunoassay (Cobas e411, Roche 
Diagnostics GmbH Marburg, Germany). Serum an-
drostenedione (ng/mL), DHEAS (µmol/L) and SHBG 
(nmol/L) were measured by radioimmunoassay 
(R-GM-100, DHEAS-CT and SHBG-RIACT, respec-
tively; CIS Bio International, Gifsur-Yvette, France). 
FAI was calculated from total testosterone and SHBG, 
using the formula FAI = (100 x T)/SHBG, and a value 
> 8 was considered elevated. Insulinogenic index as 
an indicator of beta cell response in first 60 minutes 
was calculated from OGTT [IGI = Insulin(mIU/L) 
60 min — Insulin 0 min/Glucose(mmol/L) 60 min — Glu-
cose 0 min] while insulin resistance (IR) was deter-
mined by the homeostasis model assessment [HOMA-
IR = insulin(mIU/L) x glucose(mmol/L)/22.5] [15] and 
insulin sensitivity index-Matsuda [ISI (Matsuda) = 
10000/(Fasting glucose, mg/dl x Fasting insulin, mIU/L) 
x (Mean glucose in OGTT, mg/dL x Mean insulin dur-
ing OGTT, mIU/L)] [16]. The plasma concentration of 
nitrotyrosine (nmol/L) was monitored by enzyme im-
munoassay (Oxis International Inc.). The plasma thiol 
group content (µmol/l), glutathione peroxidase activity 
(GPX, U/L), and superoxide dismutase activity (SOD, 
U/L) were determined as described elsewhere [17, 18].
Genetic testing
Genomic DNA was isolated from whole peripheral 
blood using a DNA kit (Qiagen, Chatswort, USA). Geno-
typing was performed blinded to the case-control sta-
tus, and blinded quality control samples were inserted 
to validate the genotyping identification procedures. 
Concordance for blinded samples was 100%. The DNA 
sequences of GSTM1 and GSTT1 were analysed by mul-
tiplex polymerase chain reaction according to the PCR 
protocol by Abdel-Rahman et al. [19]. The analysis of 
the SNP GSTA1 C69T (rs3957357) was performed using 
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PCR-restriction fragment length polymorphism (RFLP) 
according to the PCR protocol by Ping et al. [20]. For 
analyses of the SNP polymorphism GSTP1 Ile105Val, 
a 5’ nuclease TaqMan® SNP Genotyping Assays (Life 
Technologies, Applied Biosystems, Carlsbad, USA, assay 
ID: C__3237198_20) was used for amplification and 
detection of respective SNP alleles. 
Statistical analyses
Statistical analyses were performed using the Statisti-
cal Package for the Social Sciences software (SPSS, 
version 17.0; SPSS Inc., Chicago, Illinois, USA). The 
Kolmogorov-Smirnov test was used to evaluate the 
normality of the distributions of variables. Parametric 
continuous variables were presented as mean ± stan-
dard deviation (SD). Parametric t-test for independent 
samples was used to assess the differences between 
groups. Association between different variables were 
determined using the Pearson’s coefficient for para-
metric variables. The area under the curve AUC was 
calculated according to the trapezoid method using 
Microsoft Excel software. The significance of the differ-
ence is indicated by the p-values. A p-value of < 0.05 
was considered statistically significant.
Results
Biochemical and hormonal parameters in the 
PCOS and control groups
Clinical and biochemical parameters obtained from 
PCOS patients and age- and BMI-matched healthy 
controls are shown in Table I and Table II. There was 
no statistical difference in WC, HC, WHR, fasting blood 
glucose, indices of insulin secretion and resistance (basal 
insulin, HOMA-IR, HOMA β, IGI, ISI), as well as FSH 
between PCOS and the control group. Luteinising 
hormone, DHEAS and testosterone concentrations, as 
well as FAI values, were significantly greater (p < 0.001, 
p = 0.004, p < 0.001, p < 0.001, respectively) while pro-
gesterone and SHBG concentrations were significantly 
lower (p < 0.001, p = 0.001, respectively) in the PCOS 
adolescent girls in comparison to controls.
The baseline differences of oxidative stress param-
eters (nitrotyrosine, an indirect marker of peroxyni-
trite generation and thiol groups, established protein 
sacrificial antioxidants) and activity of antioxidant 
enzymes glutathione peroxidase (GPX) and superoxide 
dismutase (SOD) between PCOS and control subjects 
are reported in Table II. No significant difference was 
observed in GPX and SOD antioxidant activities or in 
nitrotyrosine and thiol groups, as markers of protein 
oxidative damage between groups (p > 0.05). Acute 
hyperglycaemia during OGTT induced alterations in 
both the parameters of oxidative damage of proteins 
Table II. Basal biochemical parameters in non-obese PCOS 
patients and age-matched controls
Tabela II. Podstawowe parametry biochemiczne nieotyłych 
pacjentów z PCOS i dobranych pod względem wieku osób 
z grupy kontrolnej
PCOS 
(n = 35)
Controls 
(n = 17)
p 
Glucose; OGTT 0 min 
[mmol/L]
4.47 ± 0.89 4.79 ± 0.36 0.164
Glucose; OGTT 30 min 
[mmol/L]
7.25 ± 1.14 7.20 ± 0.87 0.870
Glucose; OGTT 60 min 
[mmol/L]
7.12 ± 1.52 6.58 ± 1.06 0.198
Glucose; OGTT 90 min 
[mmol/L]
6.44 ± 1.40 5.66 ± 1.07 0.050
Glucose; OGTT 120 min 
[mmol/L]
5.61 ± 1.16 5.50 ± 0.72 0.672
Insulin; OGTT 0 min 
[mIU/L]
9.35 ± 4.11 9.34 ± 5.11 0.993
Insulin; OGTT 30 min 
[mIU/L]
85.73 ± 38.50 79.96 ± 42.06 0.625
Insulin; OGTT 60 min 
[mIU/L]
98.22 ± 48.56 78.88 ± 45.38 0.175
Insulin; OGTT 90 min 
[mIU/L]
91.61 ± 51.21 66.14 ± 33.40 0.068
Insulin; OGTT 120 min 
[mIU/L]
73.46 ± 43.69 61.53 ± 35.51 0.333
HOMA-IR 1.93 ± 0.96 1.98 ± 1.02 0.825
HOMA β 188.73 ± 129.50 250.12 ± 417.34 0.427
IGI 41.32 ± 62.24 15.02 ± 103.11 0.258
ISI (Matsuda) 4.93 ± 2.35 5.27 ± 2.55 0.636
AUC glucose 12.98 ± 1.93 12.27 ± 1.65 0.196
AUC insulin 157.80 ± 66.38 131.62 ± 51.61 0.160
FSH [U/L] 5.10 ± 1.38 5.56 ± 1.31 0.255
LH [U/L] 13.59 ± 4.34 4.97 ± 2.28 < 0.001
Testosterone [nmol/L] 2.06 ± 0.48 0.72 ± 0.28 < 0.001
SHBG [nmol/L] 21.56 ± 10.14 33.60 ± 14.40 0.001
FAI 12.43 ± 7.86 2.64 ± 1.57 < 0.001
Androstenedione [ng/mL] 1.92 ± 0.34 1.71 ± 0.43 0.068
DHEAS [μmol/L] 6.84 ± 2.64 4.69 ± 1.95 0.004
Progesterone [nmol/L] 2.52 ± 1.28 32.29 ± 9.86 < 0.001
Thiol groups [μmol/L] 10.25 ± 3.83 10.21 ± 2.21 0.967
Nitrotyrosine [nmol/L] 84.31 ± 43.02 63.79 ± 33.46 0.215
Uric acid [μmol/l] 253.70 ± 41.21 258.40 ± 20.51 0.600
GPX [U/L] 494.00 ± 140.36 505.76 ± 100.90 0.759
SOD [U/L] 106.96 ± 24.22 104.27 ± 19.44 0.711
Values are presented as mean ± standard deviation. Statistical differences 
in the variables between groups were assessed by the t-test for independent 
samples. A p-value < 0.05 was considered statistically significant
PCOS, polycystic ovary syndrome; n, number of samples; OGTT, oral glucose 
tolerance test; HOMA-IR, homeostasis model assessment of insulin resistance; 
HOMA β, homeostasis model assessment of β cell function index; IGI, 
insulinogenic index; ISI(Matsuda), insulin sensitivity index-Matsuda; FSH, follicle-
stimulating hormone; LH, luteinising hormone; SHBG, sex hormone-binding 
globulin; FAI, free androgen index; DHEAS, dehydroepiandrosterone sulphate; 
GPX, glutathione peroxidase; SOD, superoxide dismutase
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and activity of GPX enzyme in PCOS girls and controls. 
As depicted in Figure 1, in response to oral glucose 
challenge the percentage of change in both parameters 
of protein oxidative damage was more significantly 
changed in PCOS girls compared to weight-matched 
controls (p < 0.05). Namely, the percentage of change 
in nitrotyrosine was significantly higher, while change 
of thiol group content, as sacrificial protein antioxidants, 
was significantly lower in PCOS. However, change 
in activities of SOD and GPX did not reach statistical 
significance between groups (p > 0.05). 
Correlations between oxidative stress parameters 
with hormone concentrations and OGTT indices
The observed alteration of oxidative stress parameters 
during hyperglycaemia correlated with parameters of 
hyperandrogenism present in PCOS. Specifically, tes-
tosterone (including total, free, and bioavailable testos-
terone), DHEAS, androstenedione, FAI, and LH were 
positively correlated with the percentage of change 
in nitrotyrosine concentrations, and DHEAS was cor-
related with the percentage change in thiol groups (r 
= –0.425, p = 0.014) (Table III). When analysing the as-
sociation between oxidative stress markers and indices 
of insulin resistance, no significant correlations were 
obtained (data not shown). Interestingly, we found 
association of AUC for glucose with the percentage 
of change in thiol groups. However, considering the 
Figure 1. The percentage change in plasma nitrotyrosine, thiol 
groups, GPX, and SOD activity when fasting samples were 
compared with the samples collected 2 h after glucose ingestion
*the percentage change in nitrotyrosine concentrations of PCOS 
girls was greater, in comparison with that of lean controls, 
p < 0.05
#the percentage change in thiol group concentrations of PCOS 
girls showed a more pronounced decrease in comparison with that 
of controls, p < 0.05
Rycina 1. Zmiana procentowa nitrotyrozyny w osoczu, grup 
tiolowych, aktywności GPX i SOD — porównanie próbek na 
czczo z próbkami pobranymi dwie godziny po spożyciu glukozy
*zmiana procentowa stężeń nitrotyrozyny u dziewcząt z PCOS 
była większa w porównaniu z osobami szczupłymi z grupy 
kontrolnej, p < 0,05
#zmiana procentowa stężeń grup tiolowych dziewcząt z PCOS 
wykazywała wyraźniejszy spadek w porównaniu z osobami 
z grupy kontrolnej, p < 0,05
Table III. Correlations between oxidative stress markers (percentage change) and hormones in non-obese PCOS
Tabela III. Zależność między markerami stresu oksydacyjnego (zmiana procentowa) a hormonami u nieotyłych pacjentów 
z PCOS
Percentage changea
Nitrotyrosine Thiol groups GPX SOD
r p r p r p r p
FSH [U/L] –0.069 0.759 0.080 0.659 –0.207 0.232 0.072 0.762
LH [U/L] 0.496 0.036 0.068 0.697 –0.180 0.300 0.731 < 0.001
Testosterone [nnmol/L] 0.493 0.020 –0.024 0.890 –0.020 0.908 0.016 0.947
SHBG [nnmol/L] –0.365 0.095 0.172 0.338 0.065 0.711 0.067 0.752
FAI 0.491 0.020 0.020 0.913 0.085 0.626 0.078 0.743
Androstenedione 
[nmol/L]
0.568 0.006 –0.041 0.819 –0.304 0.076 –0.029 0.902
DHEAS [nnmol/L] 0.469 0.028 –0.425 0.014 –0.318 0.062 0.123 0.604
AUC glucose 0.083 0.713 –0.344 0.043 –0.100 0.566 –0.063 0.764
AUC insulin 0.285 0.198 0.110 0.531 –0.338 0.047 0.373 0.106
athe percent change in oxidative stress markers was determined when fasting samples were compared with the samples collected 2 h after OGTT
Pearson’s correlation coefficient (r) was used for all variables; significance of correlation is indicated by the p-values. A p-value < 0.05 was considered statistically significant
FSH, follicle-stimulating hormone; LH, luteinising hormone; SHBG, sex hormone-binding globulin; FAI, free androgen index; DHEAS, dehydroepiandrosterone sulphate; 
GPX, glutathione peroxidase; SOD, superoxide dismutase. 
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association between indices of insulin resistance and 
hormones of PCOS patients, significant inverse cor-
relation was found for ISI and LH (r = –0.359, p = 
0.034) (Table IV).
Evaluation of GST polymorphism in PCOS and 
control groups
The distribution of four common GST polymorphisms 
(GSTA1, GSTM1, GSTP1, and GSTT1) in PCOS adoles-
cent girls and the control group are presented in Table V. 
Specifically, deletion polymorphisms of GSTM1 and 
GSTT1 consequently result in complete absence of spe-
cific enzyme activity in GSTM1-null or GSTT1-null indi-
viduals, while carriers of GSTM1-active or GSTT1-active 
genotype have fully active enzyme. Single-nucleotide 
polymorphisms of GSTA1 and GSTP1 can result in either 
lower expression of enzyme in the case of GSTA1-variant 
or altered enzyme activity in GSTP1-variant genotype 
carriers. As presented, the observed difference in 
frequency of various GST genotypes between study 
populations and controls was not significant. 
Comparison of hormone concentrations accord-
ing to the GST genotype in the PCOS and control 
groups
The data on the hormonal status of PCOS girls (tes-
tosterone, androstenedione, DHEAS, progesterone) 
stratified according to their GST genotype are presented 
in Figure 2A-D. Adolescent girls with PCOS, carriers of 
GSTM1-null genotype, presented significantly lower 
testosterone concentrations as compared to those with 
the GSTM1-active genotype (p < 0.05) (Figure 2A).
Discussion
In this study we showed that the hormonal status of 
non-obese adolescent girls, newly diagnosed with 
PCOS could promote increased production of free 
radicals in response to glucose challenge, based on 
significant correlations between alteration of oxidative 
stress markers and testosterone, DHEAS, androsten-
edione, and LH. Moreover, we found, for the first time, 
that PCOS girls, carriers of GSTM1-null genotype, have 
significantly lower plasma concentration of testoste-
rone in comparison to PCOS carriers of GSTM1-active 
genotype, probably in relation to the ability of GSTM1 
to serve as a steroid-binding protein of testosterone.
The interplay between oxidative stress and low-
grade inflammation with hyperandrogenism and in-
sulin resistance has been extensively studied in PCOS 
[7, 11, 21, 22]. Recent evidence suggest that the major 
cause of increased generation of ROS in PCOS might be 
Table IV. Correlations between indices of insulin resistance and hormones in non-obese PCOS
Tabela IV. Zależność między wskaźnikami insulinooporności a hormonami u nieotyłych pacjentów z PCOS
Testosterone [nnmol/L] FSH [IU/L] LH [IU/L] DHEAS [nnmol/L] SHBG [nnmol/L]
r p r p r p r p r p
HOMA-IR 0.122 0.485 0.157 0.368 0.012 0.947 –0.072 0.680 –0.167 0.336
HOMA β 0.032 0.855 0.201 0.247 0.137 0.434 –0.054 0.757 0.051 0.772
IGI 0.132 0.450 0.150 0.389 0.118 0.501 –0.077 0.662 –0.276 0.109
ISI –0.173 0.321 –0.176 0.311 –0.359 0.034 –0.095 0.588 0.197 0.256
Pearson’s correlation coefficient (r) was used for all variables; Significance of correlation is indicated by the p-values. A p-value < 0.05 was considered statistically significant
FSH, follicle-stimulating hormone; LH, luteinising hormone; SHBG, sex hormone-binding globulin; DHEAS, dehydroepiandrosterone sulphate; HOMA-IR, homeostasis model 
assessment of insulin resistance; HOMA β, homeostasis model assessment of β cell function index; IGI, insulinogenic index; ISI(Matsuda), insulin sensitivity index-Matsuda
Table V. Distribution of GSTA1, GSTM1, GSTP1, and GSTT1 
genotypes in PCOS and controls
Tabela V. Rozkład genotypów GSTA1, GSTM1, GSTP1 
i GSTT1 u pacjentów z PCOS i osób z grupy kontrolnej
Variable PCOS (n, %) Controls (n, %) P
GSTA1
CC (active)
CT + TT (low activity)
15 (44.1)
19 (55.9)
3 (17.6)
14 (82.4) 0.062
GSTM1
Activea
Nullb
15 (44.1)
19 (55.9)
10 (58.8)
7 (41.2) 0.322
GSTP1
IleIle (wild type)
IleVal + ValVal 
(variant)
8 (23.5)
26 (76.5)
1 (6.2)
15 (93.8) 0.138
GSTT1
Activea
Nullb
28 (82.4)
6 (17.6)
11 (64.7)
6 (35.3) 0.161
Differences in investigated parameters were assessed by using χ2 test for 
categorical variables. A p-value < 0.05 was considered statistically significant
PCOS, polycystic ovary syndrome; n, number of samples; GSTA1, glutathione 
S-transferase alpha 1; GSTM1, glutathione S-transferase mu 1; GSTP1, 
glutathione S-transferase pi 1; GSTT1, glutathione S-transferase theta 1
aactive (present), if at least one active allele present; bnull (inactive) if no active 
alleles present; clow activity, if at least one T allele present; dvariant, if at least 
one Val allele present
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related to the impairment of the mitochondrial electron 
transport chain [23], as well as increased enzymatic ac-
tivities of NADPH oxidase and xanthine oxidase [22, 24]. 
After oral glucose challenge, a more pronounced 
increase in proinflammatory cytokine TNFα, activ-
ity of NADPH-oxidase, and different oxidative stress 
by-products was demonstrated in PCOS in contrast 
to normal weight ovulatory women [11, 21]. It seems 
that hyperandrogenaemia per se induces increased 
production of free radicals, primarily by enhanc-
ing expression and activity of NADPH-oxidase [25]. 
In a manner similar to PCOS, acute androgen treat-
ment of healthy women causes increased sensitivity 
of their leukocytes to glucose ingestion [21]. Moreover, 
a significant transient decrease in the activity of key 
antioxidant enzyme GPX during glucose challenge 
test seems to further disturb redox balance and con-
tributes to pro-oxidant state of PCOS women [11]. In 
this study, as a response to glucose challenge, we found 
the more pronounced change of oxidative stress by-
products, nitrotyrosine, and thiol groups in PCOS girls 
in comparison to controls, which is in agreement with 
our previous findings [11, 22]. Finally, data on higher 
concentrations of plasma oxidative stress parameters, 
together with unchanged activities of both key antioxi-
dant enzymes GPX and SOD in PCOS adolescent girls 
suggests subtle disturbances in redox balance in this 
early phase of PCOS clinical presentation.
Based on the similar values of basal insulin and sur-
rogate indexes of insulin resistance, PCOS adolescents 
Figure 2. The concentrations of testosterone (A), dehydroepiandrosterone sulphate (B), androstenedione (C), and progesterone (D) in 
PCOS girls according to GSTA1, GSTM1, GSTP1, and GSTT1 genotype
*adolescent girls with PCOS, carriers of GSTM1-null genotype, presented significantly lower testosterone concentrations as compared 
to those with the GSTM1-active genotype (p < 0.05)
GSTA1 genotype: low activity, if at least one T allele present (CT + TT); GSTM1 genotype: active (present) if at least one active allele 
present, null (inactive) if no active alleles present; GSTP1 genotype: wild type, if both Ile alleles are present, variant, if at least one Val allele 
present (IleVal + ValVal); GSTT1 genotype: active (present) if at least one active allele present, null (inactive) if no active alleles present
Rycina 2. Stężenia testosteronu (A), siarczanu dehydroepiandrosteronu (B), androstenedionu (C) i progesteronu (D) u dziewcząt 
z PCOS zgodnie z genotypami GSTA1, GSTM1, GSTP1 i GSTT1. Dorastające dziewczęta z PCOS, nosicielki genotypu GSTM1-null, 
wykazywały znacząco niższe stężenia testosteronu w porównaniu z dziewczętami z genotypem GSTM1-active (p < 0,05)
Genotyp GSTA1: „o niskiej aktywności” (low activity), jeśli obecny jest co najmniej jeden allel T (CT + TT);
Genotyp GSTM1: aktywny (active), jeśli obecny jest co najmniej jeden aktywny allel; zerowy (ang. null) (nieaktywny), jeśli brak jest 
aktywnych alleli;
Genotyp GSTP1: typ dziki (wild type), jeśli obecne są oba allele Ile; wariant (ang. variant), jeśli co najmniej jeden allel Val jest obecny 
(IleVal + ValVal);
Genotyp GSTT1: aktywny (active), jeśli obecny jest co najmniej jeden aktywny allel; zerowy (null) (nieaktywny), jeśli brak jest 
aktywnych alleli
A B
C D
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in the present study were not considered as insulin 
resistant. Therefore, the increased production of ROS 
in the PCOS group is probably related to hyperandro-
genism. Still, significant inverse correlation between 
ISI and LH, as well as the association of AUC for 
glucose with oxidative stress alteration during OGTT 
(thiol groups) obtained in our study could provide 
important information towards predicting insulin 
resistance in newly diagnosed PCOS adolescents. 
Further examination of potential link between insulin 
resistance and oxidative stress would also include the 
investigation of these parameters after euglycaemic-
hyperinsulinaemic clamp, especially bearing in mind 
the recent study on the limited value of surrogate in-
dices in estimation of insulin resistance in PCOS [26]. 
Nevertheless, the clear associations between plasma 
testosterone levels, DHEAS, androstenedione and 
LH, and alternated concentrations of oxidative stress 
parameters during acute hyperglycaemia support the 
assumption that hyperandrogenism might be the pro-
genitor of diet-induced oxidative stress in PCOS. For 
further confirmation on the link between the hormo-
nal status and oxidative stress, especially in predicting 
early vascular damage, more focused analyses and 
consequent follow-up of the larger cohort of PCOS 
patients are needed.
It is important to note that transient decrease in 
GPX activity together with increasing oxidative stress 
by-products in healthy controls as a consequence of 
glucose challenge actually represents physiological 
response, necessary for proper insulin signalling. Re-
garding insulin signalling cascade, binding of insulin 
to its receptor results in enhanced ROS production, by 
the activation of NADPH oxidases and inhibition of 
membrane antioxidant enzyme peroxiredoxin I [27]. 
In that way, oxidative redox environment favours 
the propagation of the insulin signalling cascade by 
enhancing kinase activity with simultaneous inhibi-
tion of protein tyrosine phosphatase [27, 28]. On the 
other hand, the excessive load of ROS might affect the 
activity of redox-sensitive PI3K–PDK1–Akt signalling 
axis, as demonstrated for free radical peroxynitrite, con-
tributing to the development of insulin resistance [27]. 
These findings offer new insight into the role of free 
radicals and oxidative stress, especially according to 
new definition, in which the term “oxidative eustress” 
denotes physiological oxidative stress and serves in 
the distinction from excessive load, “oxidative distress”, 
which causes oxidative damage [29].
In addition to detoxifying xenobiotics and free radi-
cals, the GST superfamily is also involved in catalysing 
the conjugation of different endogenous substrates, 
including steroids and prostaglandins [30]. What is 
more, GSTs may also act as binding proteins for bile 
acids, steroid hormones, and neurotransmitters [30]. 
Almost all cytosolic members of the GSTs exhibit 
genetic polymorphism, resulting in complete lack or 
alteration in enzyme activity [30, 31]. Consequently, 
great inter-individual differences in GST genotype ex-
ist, affecting individual biotransformation ability and 
potential ligand-binding capacity. Specifically, GSTM1 
serves as a steroid-binding protein with the ability to 
bind testosterone and estradiol. To our knowledge, 
polymorphisms in common cytosolic GSTs have not 
yet been analysed in such a context in PCOS. Interest-
ingly, we found that in PCOS girls, in whom GSTM1 
enzyme is absent as a consequence of GSTM1-deletion 
polymorphism (carriers of GSTM1-null genotype) 
circulating testosterone was significantly lower in 
comparison to ones with GSTM1-active genotype. Fur-
ther analysis of the potential role of GSTs in hormonal 
disturbance in PCOS seems to be a new promising 
approach in PCOS treatment.
In conclusion, our adolescent girls with PCOS ex-
hibited high production of free radicals together with 
unchanged antioxidant enzymatic capacity, indepen-
dently from obesity and insulin resistance. This sug-
gests that increased free radical production, probably as 
a consequence of hyperandrogenaemia happens in the 
early phase of PCOS and could contribute to further 
development of insulin resistance and other metabolic 
disturbances associated with this syndrome. Therefore, 
a primary prevention model of reducing oxidative stress 
by means of antioxidant supplementation and regular 
exercise training [32], may be beneficial in patients with 
polycystic ovary syndrome.
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